Shared Care Guidelines: Paediatric use of Recombinant human Growth Hormone (r-hGH, Somatropin)

Shared Care Guidelines: Paediatric use of Recombinant human Growth Hormone (r-hGH, Somatropin) - British Society for Paediatric Endocrinology and Diabetes (BSPED)

r-hGH is administered by subcutaneous injection or needle free transjection, once daily. Depending on the brand, injections may be prepared from multi-dose ampoules or by using cartridges in a multi-dose pen injection device or other disposable devices. r-hGH has a role in protein, lipid and carbohydrate metabolism, in addition to increasing linear growth in children.


Read full Guideline